This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Leukaemia
  • /
  • Chronic myeloid leukemia: ESMO Clinical Practice G...

Chronic myeloid leukemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Read time: 1 mins
Last updated:1st Jul 2017
Chronic Myeloid Leukaemia: ESMO Clinical Practice Guidelines - European Society for Medical Oncology (ESMO)

The prevalence of chronic myeloid leukaemia is steadily rising due to the substantial prolongation of survival that has been achieved with targeted therapy. These updated guidelines on chronic myeloid leukaemia provide updated treatment recommendations including the monitoring and management of side effects, as well as a new treatment algorithm for chronic phase chronic myeloid leukaemia patients.


Read full guideline